CollPlant Biotechnologies (CLGN) Price to Earnings (2018 - 2026)
CollPlant Biotechnologies' (CLGN) quarterly Price to Earnings came in at 0.24 in Q1 2026, up 86.32% on a YoY basis from 0.13 in Q1 2025, and up 57.38% quarter-over-quarter from 0.57 in Q4 2025.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Price to Earnings (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies (CLGN) has reported Price to Earnings for 9 consecutive years, with 0.24 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Price to Earnings rose 86.32% year-over-year to 0.24; the trailing twelve-month figure through Mar 2026 stood at 0.11 (up 77.42% YoY), and the FY2025 full-year result was 0.16, up 35.35% from the prior year.
- Price to Earnings rose to 0.24 in Q1 2026 per CLGN's latest filing, from 0.57 in the prior quarter.
- Across five years, Price to Earnings topped out at 3.21 in Q1 2022 and bottomed at 2.06 in Q2 2022.
- Historically, Price to Earnings has averaged 0.24 across 5 years, with a median of 0.88 in 2025.
- The sharpest annual moves came in 2022 and 2025: Price to Earnings surged 245.97% in 2022, then sank 225.22% in 2025.
- Over 5 years, Price to Earnings stood at 2.0 in 2022, then climbed by 27.71% to 1.44 in 2023, then rose by 28.14% to 1.04 in 2024, then surged by 45.16% to 0.57 in 2025, then jumped by 57.38% to 0.24 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 0.24, 0.57, and 0.88 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | CollPlant Biotechnologies | 4.17 Mn | 4.17 Mn | -243,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2026 | -0.24 |
| Dec 31, 2025 | -0.57 |
| Sep 30, 2025 | -0.88 |
| Jun 30, 2025 | 0.49 |
| Mar 30, 2025 | -1.77 |
| Dec 31, 2024 | -1.04 |
| Sep 30, 2024 | -1.25 |
| Jun 30, 2024 | 1.29 |
| Mar 31, 2024 | 1.42 |
| Dec 31, 2023 | -1.44 |
| Sep 30, 2023 | -1.35 |
| Jun 30, 2023 | 1.61 |
| Mar 31, 2023 | 2.23 |
| Dec 31, 2022 | -2.00 |
| Sep 30, 2022 | -1.64 |
| Jun 30, 2022 | -2.06 |
| Mar 31, 2022 | 3.21 |
| Dec 31, 2021 | -4.67 |
| Sep 30, 2021 | -3.90 |
| Jun 30, 2021 | -4.95 |